SURGICAL ONCOLOGY RESEARCH TRAINING PROGRAM AT PENN

宾夕法尼亚大学肿瘤外科研究培训项目

• 批准号: 10202527
• 负责人: Ronald P Dematteo
• 金额: $ 39.06万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-07-01 至 2025-06-30
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10202527
• 关键词: Research Training; Surgical Oncology; Training Programs

ABSTRACT We propose a new program of training in cancer research for surgery residents pursuing a career in academic Surgical Oncology. The rationale is that there is a nationwide shortage of surgeon-scientists. A T32 program would enable us to train high caliber surgical trainees so that they can contribute to new cancer therapies and discoveries, improve the care of cancer patients, and mentor future trainees. T32 trainees will have already completed 3 years of postgraduate clinical training in surgery. The 2-year T32 training program will provide an intensive research experience in hypothesis formulation, experimental design, research techniques, data analysis, and oral and written presentation. After completing the T32 program, the trainees return to the clinic for the 2 final clinical years of residency. Most pursue an additional 2 years of fellowship specialization after finishing residency training. The ultimate objective of the program is to train surgeon-scientists to perform oncologic research upon completion of their surgical training and become leaders in academic surgical oncology. We propose a total of 2 mentees in the first year, 5 mentees in the second year, and six mentees per year in years 3-5. The program will have a Basic/Translational Track and a Clinical Track, which reflects the strengths of our faculty and the interests of our residents. The program will leverage the vast research opportunities and infrastructure of the Perelman School of Medicine and the University of Pennsylvania, including the Abramson Cancer Center. The program is a major priority of the Department of Surgery, which has a longstanding history of training surgeon-scientists and academic leaders. The T32 Program will be managed by the Program Director, 2 Associate Program Directors, and a Steering Committee, with input from highly experienced advisors (3 internal and 2 external). The 16 mentors are based in Surgery and 8 other departments. The mentors have active funding, a track record of mentoring, and expertise in a wide variety of disciplines, including tumor immunology, cancer cell biology, cancer imaging, and clinical cancer research. The proposed curriculum is robust and will be tailored to the specific needs of each trainee. There will be instruction in the Responsible Conduct of Research, grant writing workshops, oral presentation skill sessions, and journal clubs. T32 trainees will also have the opportunity to obtain an advanced degree, such as a Masters in Translational Medicine or Clinical Epidemiology, and even a PhD. Our department has several initiatives to promote diversity through the recruitment of women and underrepresented minorities.

抽象的 我们建议一项新的癌症研究培训计划 学术外科肿瘤学。理由是全国范围内的外科医生科学家短缺。一个 T32计划将使我们能够培训高素质的手术学员，以便他们可以为新的 癌症疗法和发现，改善癌症患者的护理以及指导未来的学员。 T32 学员将完成3年的手术研究生临床培训。 2年T32 培训计划将在假设配方，实验中提供密集的研究经验 设计，研究技术，数据分析以及口头和书面演示。完成T32后 计划，学员返回诊所的居住期限为2个临床年份。大多数追求 完成居住培训后，另外2年的研究金专业。最终目标 该计划是培训外科医生科学家在完成手术后进行肿瘤学研究 培训并成为学术外科肿瘤学领导者。我们在第一个中总共提议2名受训者 年份，第二年有5名受训者，每年3 - 5年每年有6名受训者。该程序将有一个 基本/翻译轨道和临床轨道，这反映了我们教职员工的优势 我们居民的利益。该计划将利用庞大的研究机会和基础设施 佩雷尔曼医学院和宾夕法尼亚大学，包括艾布拉姆森癌 中心。该计划是手术部的重点 培训外科医生科学家和学术领袖。 T32程序将由程序管理 董事，2名副计划主任和一个指导委员会，并有经验丰富的意见 顾问（3个内部和2个外部）。 16位导师设在手术和其他8个部门。这 导师拥有积极的资金，指导的记录以及各种学科的专业知识， 包括肿瘤免疫学，癌细胞生物学，癌症成像和临床癌症研究。这 拟议的课程很健壮，将根据每个学员的特定需求进行量身定制。将有 负责任的研究，授予写作研讨会，口头演示技巧的指导 会议和期刊俱乐部。 T32学员还将有机会获得高级学位， 例如转化医学或临床流行病学的硕士学位，甚至是博士学位。我们的部门 有几项举措通过招募妇女而促进多样性和人为不足 少数民族。